Live Breaking News & Updates on Pharmaceutical Industry In China

Stay updated with breaking news from Pharmaceutical industry in china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

We are pleased to partner with Irom in Japan to bring this important biosimilar to the market. Biosimilars are a key growth driver for Lupin, and through products such as this, we are making significant progress in improving access and affordability of im

It can result in severe clinical consequences, such as back pain and bone fractures particularly in the spine and hips,” said Dr. Cyrus Karkaria, President – Biotechnology, Lupin. ....

South Africa , Asia Pacific , Cyrus Karkaria , Biotechnology Pharmaceuticals , Irom Group , Latin America , Middle East , Great Place , Brand Promise , I Rom Group , Back Pain , Medical Technology , Pharmaceutical Industry , Pharmaceuticals Policy , Generic Drug , Pharmaceutical Industry In China , Pharmaceutical Industry In India ,

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull

In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young LLP as the Company s auditors and approving the unallocated shares, rights and other entitlements under the Company s share purchase plan. ....

United States , Harold Wolkin , Christian Godin , Cathy Steiner , Arthur Deboeck , Cipher Pharmaceuticals , Cipher Pharmaceuticals Inc , Company Board , Ernst Young , Health Canada , John Mull , North America , Financial Statements , Food And Drug Administration , Forward Looking Statement , Merger And Acquisition , Mergers And Acquisitions , Pharmaceutical Industry , Pharmaceutical Industry In China , Regulations K , Sec Rule 10b 5 ,

Ampio Pharmaceuticals, Inc. to Hold Conference Call

ENGLEWOOD, Colo., April 27, 2022 Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potentially other articular joints, announced that the Company will be hosting a ....

United States , Ampio Pharmaceuticals , Drug Administration , Ampio Pharmaceuticals Inc , Investor Update Call , Biologics Price Competition , Innovation Act , Clinical Trial , Conference Call , Food And Drug Administration , Forward Looking Statement , Health Sciences , Life Sciences , Pharmaceutical Industry , Pharmaceutical Industry In China ,

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Misoprostol Tablets, 100 mcg and 200 mcg. ....

United States , Nikhil Lalwani , Exchange Commission , Company Nasdaq , Drug Administration , Pharmaceuticals Inc , Misoprostol Tablets , Reference Listed Drug , Chief Executive Officer , Purified Cortrophin , North American , Private Securities Litigation Reform Act , Forward Looking Statement , Health Sciences , Life Sciences , Pharmaceuticals Policy , Generic Drug , Pharmaceutical Industry In China ,

Oramed to Present at Barclays Global Healthcare Conference

The presentation will be webcasted and can be viewed through the following link for up to 90 days following the presentation: https://cc.webcasts.com/barc002/031522a js/?entity=92 X7NI2JC. ....

United States , Nadav Kidron , Eric Goldstein , Zach Herschfus , Exchange Commission , Oramed Pharmaceuticals Inc , Company Contacts , Oramed Pharmaceuticals , Oramed Pharmaceuticals Nasdaq , Chief Executive Officer , Barclays Global Healthcare , Protein Oral Delivery , Clinical Trial , Forward Looking Statement , Pharmaceutical Industry In China ,